article thumbnail

STAT+: Telehealth companies that prescribed controlled substances during the pandemic brace for business to change

STAT

Health tech companies that have taken advantage of the possibility to prescribe controlled substances online during the pandemic may soon find their businesses — and their ability to care for patients — in jeopardy. 

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog: Biosimilars

Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. On October 10th, based on ability to pay, the U.S. 6, 2023 ( DOJ Press Release ). Zarzamora Press Release.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telehealth patients are scrambling for in-person care amid crackdown on online controlled substances

STAT

Catherine was getting nervous about her ADHD prescription. In 2022, the 29-year-old New Yorker had started using Done, a direct-to-consumer telehealth company that treats attention deficit hyperactivity disorder.

article thumbnail

STAT+: Key lawmakers pressure Biden to preserve telehealth prescribing of effective addiction treatment

STAT

urged the DEA to continue allowing health providers to prescribe buprenorphine, a controlled substance used to treat opioid addiction, without requiring an in-person visit.    Prior to the Covid-19 pandemic, any patient who needed a controlled substance was required to be examined in person before receiving a prescription.

article thumbnail

STAT+: Frustrated telehealth providers say their businesses face ‘doom and gloom’

STAT

With just months to go before the ability to prescribe controlled substances online dramatically changes overnight, the vacuum of information is forcing them to devote significant energy preparing for the unknown.

article thumbnail

STAT+: Feds accuse CVS of filling ‘thousands’ of illicit opioid prescriptions

STAT

The lawsuit alleged that, since October 2013, CVS knowingly filled prescriptions for “dangerous and excessive quantities” of controlled substances that lacked a legitimate medical purpose, were not valid, and were not issued in the “usual course of professional practice.” Department of Justice.

article thumbnail

Opinion: Breakthrough Therapies Act: Good idea, wrong solution

STAT

as a way to expand access for therapeutic purposes to potentially beneficial but highly regulated Schedule I substances like psilocybin and LSD, has the right underlying idea but provides a solution that is wrong. The Breakthrough Therapies Act , recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.)